01 / Guideline numbers
What the guidelines say about this number
Normal vs optimal
We found no current US guideline that publishes a normal or optimal hs-CRP. The only current line is the 2026 risk enhancer at 2 mg/L or higher.
02 / Why it matters
What the number tells you
The 2026 ACC/AHA dyslipidemia guideline, published online March 13, 2026, lists hs-CRP in its table of risk enhancers as "hsCRP ≥2 mg/L on >1 occasion (if measured)": a level of 2 mg/L or higher on more than one occasion, for adults without atherosclerotic cardiovascular disease (ASCVD) in primary prevention. It is one of ten rows in that table, beside numeric cuts for Lp(a), triglycerides, LDL-C, non-HDL-C and apoB. ACC's December 2025 article on hs-CRP, written under the previous guideline, gives the same number: "an hsCRP ≥2 mg/L is considered a risk-enhancing factor in current guidelines". Two one-page corrections to the guideline were published on June 22 and September 8, 2026, and we could not read them, so the number here is as printed in ACC's reproduction of the guideline's tables, read October 19, 2026.
03 / In practice
Testing and what moves it
When it is tested
- Selectively, in ACC's reading of the 2026 guideline: its April 2026 top-10 summary says coronary calcium scoring and "hsCRP are recommended selectively to refine risk assessment" when traditional risk estimates are uncertain.
- If it is measured, the 2026 risk enhancer counts only a level of 2 mg/L or higher on more than one occasion, so one result cannot meet it alone.
- ACC's 2025 scientific statement on inflammation and cardiovascular disease goes further. ACC's December 2025 article reports that it "now recommends universal screening of hsCRP in both primary and secondary prevention".
What raises it
- Acute infection or injury, obesity and insulin resistance, smoking, chronic inflammatory disease, poor sleep, some medications (estrogen).
What lowers it
- Weight loss, exercise, stopping smoking, statins (which lower hs-CRP independently of LDL-C).
04 / Related
Read next
Frequently asked questions
What is a normal hs-CRP?
We found no current US guideline that publishes a normal hs-CRP range. The current line is in the 2026 ACC/AHA dyslipidemia guideline: 2 mg/L or higher, on more than one occasion, counts as a risk enhancer for adults without ASCVD.
Is hs-CRP the same as CRP?
Same protein, different assay range. Standard CRP is used to track infection and inflammatory disease at higher concentrations; hs-CRP resolves the low levels that matter for cardiovascular risk.
Should everyone get an hs-CRP test?
ACC documents point two ways. ACC's April 2026 summary of the dyslipidemia guideline describes hs-CRP as recommended selectively to refine risk assessment when traditional risk estimates are uncertain, while ACC reports that its own 2025 inflammation statement recommends universal screening in both primary and secondary prevention. Neither the guideline tables we read nor the statement's abstract gives a normal range.
One document sets the numbers on this page, published in 2026.
We last re-read these sources on . How we verify.